Cochlear (CHEOF) Stock Price, News & Analysis

Company Overview

Cochlear (OTCMKTS:CHEOF) is a global medical device company specializing in implantable hearing solutions. The company researches, develops, manufactures and markets cochlear implants, bone conduction hearing devices and acoustic implants designed to improve hearing outcomes for individuals with varying degrees of hearing loss. Cochlear’s product portfolio includes implant processors, electrode arrays and sound processor accessories, supported by proprietary digital signal processing technologies.

Founded in 1981 and headquartered in Sydney, Australia, Cochlear has grown into a multi-national organization with operations in North America, Europe, Asia Pacific and Latin America. The company operates manufacturing facilities in Australia and Europe and maintains regional offices and distribution centers in key markets to support clinical partners and rehabilitation services. Cochlear’s global footprint ensures that its hearing implants and related services are available to patients in more than 100 countries worldwide.

Beyond its core implantable devices, Cochlear offers a suite of services that include pre- and post-operative care, device mapping and patient support programs. The company invests in ongoing research and development to advance hearing performance through wireless connectivity, remote care platforms and next-generation implant designs. Cochlear collaborates with leading universities, hospitals and audiology clinics to drive innovation in auditory science and rehabilitation protocols.

Supported by a specialized management team and a network of clinical partners, Cochlear remains committed to expanding access to implantable hearing solutions. Through training programs for surgeons and audiologists, as well as outreach initiatives for patient communities, the company seeks to enhance long-term outcomes and quality of life for individuals affected by hearing impairment.

Key Stats

• Today's Range: $94.89 to $94.89
• 50-Day Range: $78.95 to $96.79
• 52-Week Range: $64.39 to $207.71
• Volume: N/A
• Average Volume: 1,506 shs
• Market Capitalization: N/A
• P/E Ratio: 57.79
• Dividend Yield: 1.34%
• Price Target: N/A
• Consensus Rating: N/A

Cochlear Stock Analysis - MarketRank™

Cochlear scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cochlear.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cochlear is 57.79, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.29.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cochlear is 57.79, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.97.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cochlear has a short interest ratio ("days to cover") of 520.88, which indicates bearish sentiment.

Change versus previous month

Short interest in Cochlear has recently decreased by 23.59%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Cochlear pays a meaningful dividend of 2.07%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cochlear does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Cochlear is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

News Sentiment

Cochlear has a news sentiment score of -0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Cochlear this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cochlear insiders have not sold or bought any company stock.

Percentage Held by Institutions

22.47% of the stock of Cochlear is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CHEOF
• CIK: 1453930
• Web: www.cochlear.com
• Phone: (129) 428-6555
• Fax: N/A
• Employees: 4,800
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 57.79
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A